JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wajon, P.
Right arrow Articles by Thrift, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wajon, P.
Right arrow Articles by Thrift, B.
Related Collections
Right arrow Blood
Right arrow Heart
Anesth Analg 2001;93:536-542
© 2001 International Anesthesia Research Society


CARDIOVASCULAR ANESTHESIA

Intraoperative Plateletpheresis and Autologous Platelet Gel Do Not Reduce Chest Tube Drainage or Allogeneic Blood Transfusion After Reoperative Coronary Artery Bypass Graft

Paul Wajon, FFARACS, FANZCA, John Gibson, FANZCA, Ross Calcroft, FANZCA, FFICANZCA, Clifford Hughes, FRACS, and Brian Thrift, ASOTT

Departments of Anaesthetics and Cardiothoracic Surgery, Royal Prince Alfred Hospital, Camperdown NSW, Australia

Address correspondence to Dr. Paul Wajon, MB, BS, FFARACS, FANZCA, P.O. Box 70, Gladesville NSW, Australia 1675. Address e-mail to pwajon{at}ozemail.com.au No reprints will be available from the author.

Platelet-rich plasma (PRP) is postulated to decrease postoperative mediastinal chest tube drainage (MCTD) and allogeneic blood transfusions (ABT) after surgery with cardiopulmonary bypass. However, recent metaanalysis of the literature reveals that few good quality (therapeutic yield) trials that show a benefit have been published. The potential hemodynamic instability caused by plateletpheresis has not been emphasized. We studied the effect of plateletpheresis on MCTD, ABT, and hemodynamic stability in reoperative coronary artery bypass graft patients, a group perceived to be at high risk for ABT. Ninety patients were randomly assigned to Pheresis or Control groups. {epsilon}-Aminocaproic acid was given to all patients. Hemodynamic instability was assessed by degree of volume and inotrope resuscitation required. Part of the sequestered platelet volume was used to make autologous platelet gel, which was applied as a wound sealant. Mean pheresis yield was 30% ± 7% of the circulating platelet mass or 6.4 ± 2.2 allogeneic platelet unit equivalents. Total MCTD did not differ between the groups. There were no differences in mean packed red blood cell, platelet, and plasma transfusion rates. Overall, 52% of the Pheresis group received ABT, versus 55% of the Control group. Fifty-three percent of the Pheresis group patients exhibited significant hemodynamic instability, versus 27% of the Control group (P < 0.05). This study was unable to show any reduction in MCTD or ABT, although the plateletpheresis technique may offset platelet dysfunction caused by aspirin or increased blood exposure to nonbiologic surfaces, or it may compensate for lack of antifibrinolytic use. The significantly increased incidence of hemodynamic instability in the Pheresis group means that the risk/benefit ratio must be determined for individual cardiac surgical units.

IMPLICATIONS: This trial of plateletpheresis in reoperative coronary artery surgery was performed to assess its effect on allogeneic blood product transfusion. Routine antifibrinolytic usage, minimal aspirin, and nonbiologic surface exposure seem to negate any benefit of the technique in these patients. These findings differ from those of other recent reports. The study also emphasizes the potential hemodynamic disturbances related to the pheresis process.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. McGrath, C. G. Koch, M. Xu, L. Li, T. Mihaljevic, P. Figueroa, and E. H. Blackstone
Platelet transfusion in cardiac surgery does not confer increased risk for adverse morbid outcomes.
Ann. Thorac. Surg., August 1, 2008; 86(2): 543 - 553.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. S. Avidan, E. L. Alcock, J. Da Fonseca, J. Ponte, J. B. Desai, G. J. Despotis, and B. J. Hunt
Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery
Br. J. Anaesth., February 1, 2004; 92(2): 178 - 186.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. R. Belcher, E. W. Muriithi, P. Wajon, and J. Gibson
Postoperative Bleeding After Coronary Artery Bypass Surgery with Cardiopulmonary Bypass * Response
Anesth. Analg., November 1, 2002; 95(5): 1466 - 1467.
[Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.